Shows / CANCER BUZZ

CANCER BUZZ
CANCER BUZZ features fresh perspectives on hot topics in oncology care delivery. CANCER BUZZ is where stakeholders from the front lines of care to the C-suite, from research to the registry, from chairside to benchside, talk about top-of-mind questions and real-world impact.
The show, from its episodes
No episode notes yet. Recurring topics, people and starter picks will appear when notes are available.
Typical episode length
6m · median of 316 episodes with a known length
Solo / guest format
Unknown — existing notes name people mentioned, but do not identify hosts or guests.
Recurring topics
No recurring topics established yet.
Recurring people
No recurring people established yet.
Start here
No starter picks yet — no published episodes with audio and a recorded notes hook.
Episodes
CANCER BUZZWhat Comes Next for Telehealth?
Long lagging in acceptance from providers, patients, and payers, telehealth has undergone a renaissance in use due tothe COVID-19 pandemic, enabling millions…
CANCER BUZZWhat You Need to Know about Liquid Biopsy
Five years ago, the FDA approved the first liquid biopsy test for use in patients with cancer, providing cancer teams and patients a less invasive and more…
CANCER BUZZThe Spiritual Side of Cancer Care
Spiritual care teams can play a significant role in helping patients with cancer manage their fear and find a sense of peace. On this mini-podcast, learn why…
CANCER BUZZTelehealth & Genetics During COVID-19
Since the onset of the COVID-19 pandemic, telehealth has become a much wider practice, enabling millions to receive care at home. Genetic screening, testing…
CANCER BUZZEnd-of-Life Health Disparities
Palliative care isn't just about the end of life, it's also about improving the quality of life for patients and caregivers—but challenges exist for minority…
CANCER BUZZCultural Humility & Sensitivity
From unethical experimentation to systematic exclusion, racism has played a terrible role in the development of American healthcare. On this mini-podcast, we…
CANCER BUZZTracking Patient Adherence to Oral Anti-Cancer Medications
Oral anti-cancer medications are one of the most important recent developments in oncology: less invasive than infusions, able to be taken at home, and…
CANCER BUZZBuilding Trust with Marginalized Groups
In healthcare, Implicit and unconscious bias can manifest in many ways. On this mini-podcast, discover what steps cancer programs can take to build trust with…
CANCER BUZZLGBTQ+ Patients with Cancer
Sexual and gender minority patients with cancer experience health disparities that impact access to screening and treatment—and can have worse outcomes as a…
CANCER BUZZTelehealth After COVID-19
Long lagging in acceptance from providers, payers, and patients, telehealth has undergone a renaissance in 2020, enabling millions of people to receive…
CANCER BUZZSupporting Caregivers During COVID-19
Friends, family, and loved ones are essential parts of a patient's support system, but COVID-19 has altered their access to the care process and to care…
CANCER BUZZPsychosocial Oncology Services During COVID-19
The COVID-19 pandemic has affected every corner of American cancer care—including psychosocial services. On this mini-podcast, we explore how patients are…
CANCER BUZZThe Promise of Bispecific Antibodies
The redirection of T cells against tumors holds significant promise for the treatment of cancer. Two main approaches for T-cell redirection involve their…
CANCER BUZZLung Cancer Screening During COVID-19
As part of Lung Cancer Awareness Month, we take a look at how the COVID-19 pandemic has impacted lung screenings across the country and how oncology teams are…
CANCER BUZZManaging Oral Anti-Cancer Medications
As the number of oral anti-cancer medications continues to grow, so do new challenges in education, care delivery, and patient adherence to treatment…
CANCER BUZZLung Cancer Awareness Month
On this mini-podcast, we mark the beginning of Lung Cancer Awareness Month by looking at the present landscape for the diagnosis and treatment of one of the…